Source:http://linkedlifedata.com/resource/pubmed/id/15471982
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-1-14
|
pubmed:abstractText |
Myosin heavy chain (MHC) isoforms alpha and beta have intrinsically different ATP hydrolysis activities (ATPase) and therefore cross-bridge cycling rates in solution. There is considerable evidence of altered MHC expression in rodent cardiac disease models; however, the effect of incremental beta-MHC expression over a wide range on the rate of high-strain, isometric cross-bridge cycling is yet to be ascertained. We treated male rats with 6-propyl-2-thiouracil (PTU; 0.8 g/l in drinking water) for short intervals (6, 11, 16, and 21 days) to generate cardiac MHC patterns in transition from predominantly alpha-MHC to predominantly beta-MHC. Steady-state calcium-dependent tension development and tension-dependent ATP consumption (tension cost; proportional to cross-bridge cycling) were measured in chemically permeabilized (skinned) right ventricular muscles at 20 degrees C. To assess dynamic cross-bridge cycling kinetics, the rate of force redevelopment (ktr) was determined after rapid release-restretch of fully activated muscles. MHC isoform content in each experimental muscle was measured by SDS-PAGE and densitometry. alpha-MHC content decreased significantly and progressively with length of PTU treatment [68 +/- 5%, 58 +/- 4%, 37 +/- 4%, and 27 +/- 6% for 6, 11, 16, and 21 days, respectively; P < 0.001 (ANOVA)]. Tension cost decreased, linearly, with decreased alpha-MHC content [6.7 +/- 0.4, 5.6 +/- 0.5, 4.0 +/- 0.4, and 3.9 +/- 0.3 ATPase/tension for 6, 11, 16, and 21 days, respectively; P < 0.001 (ANOVA)]. Likewise, ktr was significantly and progressively depressed with length of PTU treatment [11.1 +/- 0.6, 9.1 +/- 0.5, 8.2 +/- 0.7, and 6.2 +/- 0.3 s(-1) for 6, 11, 16, and 21 days, respectively; P < 0.05 (ANOVA)] Thus cross-bridge cycling, under high strain, for alpha-MHC is three times higher than for beta-MHC. Furthermore, under isometric conditions, alpha-MHC and beta-MHC cross bridges hydrolyze ATP independently of one another.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/HL/DK-R01-63704,
http://linkedlifedata.com/resource/pubmed/grant/HL-64942,
http://linkedlifedata.com/resource/pubmed/grant/HL-P01-62426,
http://linkedlifedata.com/resource/pubmed/grant/T32-HL-072742,
http://linkedlifedata.com/resource/pubmed/grant/T32-HL-07692
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Triphosphate,
http://linkedlifedata.com/resource/pubmed/chemical/Antithyroid Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Bmyo protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/Myosin Heavy Chains,
http://linkedlifedata.com/resource/pubmed/chemical/Propylthiouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Ventricular Myosins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0363-6135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
288
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
H896-903
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15471982-Adenosine Triphosphate,
pubmed-meshheading:15471982-Animals,
pubmed-meshheading:15471982-Antithyroid Agents,
pubmed-meshheading:15471982-Hypothyroidism,
pubmed-meshheading:15471982-Isomerism,
pubmed-meshheading:15471982-Kinetics,
pubmed-meshheading:15471982-Male,
pubmed-meshheading:15471982-Myocardial Contraction,
pubmed-meshheading:15471982-Myocytes, Cardiac,
pubmed-meshheading:15471982-Myosin Heavy Chains,
pubmed-meshheading:15471982-Propylthiouracil,
pubmed-meshheading:15471982-Rats,
pubmed-meshheading:15471982-Rats, Inbred Lew,
pubmed-meshheading:15471982-Ventricular Myosins
|
pubmed:year |
2005
|
pubmed:articleTitle |
Impact of beta-myosin heavy chain isoform expression on cross-bridge cycling kinetics.
|
pubmed:affiliation |
Center for Cardiovascular Research, Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|